Swadi, Asma Abdul Jaleel
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Metabolic Improvements From CoQ10 and ALA in PCOS Patients Hussein, Dhirgham Saif Aldean; Kadhim, Sinaa Abdul Amir; Swadi, Asma Abdul Jaleel
Indonesian Journal on Health Science and Medicine Vol. 2 No. 2 (2025): Oktober
Publisher : Universitas Muhammadiyah Sidoarjo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21070/ijhsm.v2i2.197

Abstract

Background: As more women search for natural solutions or prescription medications to manage their symptoms, supplements like Alpha Lipoic Acid and CoQ10 are growing in popularity. Combining these with a personalized plan can lead to better health outcomes and a higher quality of life. Aim of the study: the aim of the current research project is to evaluate the effect of combined administration of metformin, ALA and CoQ10 on PCOS metabolic and fertility parameters. Patients and methods: This clinical trial, which was randomized, single-blind, and actively controlled, took place in Diwaniyah, Iraq, from October 2024 to June 2025. Participants were randomly assigned to three different groups. The random assignment was carried out using computer-generated random numbers. Patients in Group Met. received Glucophage (500 mg; Merck, West Drayton, UK) three times per day; Group Met.+ALA patients were given metformin as in the first group along with ALA (600 mg, Batch no. 6N5483; Holzkrichen, Bavaria, Germany) three times daily; Group Met.+ALA+CoQ10 patients received metformin and ALA as in the second group, along with 200 mg of CoQ10 each day. All treatments were provided over a duration of 12 weeks. Result: Post-treatment, all three forms of management showed significant decline in average free Testosterone, LH and LH:FSH ratio, GnRH anti-body and ovarian volume (p < 0.001); the effect of Met. plus ALA plus CoQ10 was significantly more profound when contrasted to other 2 modes of therapy (p < 0.05). However, none of these treatment approaches was able to affect serum levels of FSH, prolactin and TSH significantly (p > 0.05).Conclusion: The combined use of metformin therapy, CoQ10 supplements and ALA supplements is associated with the most optimum hormonal and ultrasound characteristic in PCOS women by reducing the pathogenic effect of anti GnRHR antibody level. Highlights: Combined Metformin, ALA, and CoQ10 improved hormonal and ultrasound parameters in PCOS. Significant reductions were observed in LH, free testosterone, LH:FSH ratio, and ovarian volume. No significant changes were found in FSH, prolactin, or TSH levels. Keywords: Polycystic Ovary Syndrome, Metformin, Alpha Lipoic Acid, Co-Enzyme Q10
Impact of Smoking on Adalimumab Response and Biomarkers in Rheumatoid Arthritis: Dampak Merokok terhadap Respons Adalimumab dan Biomarker pada Pasien Artritis Reumatoid Abed, Ghasaq Kareem; Swadi, Asma Abdul Jaleel
Indonesian Journal on Health Science and Medicine Vol. 3 No. 1 (2026): July
Publisher : Universitas Muhammadiyah Sidoarjo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21070/ijhsm.v3i1.454

Abstract

General Background: Rheumatoid arthritis is a chronic autoimmune disease characterized by persistent inflammation and joint destruction. Specific Background: Adalimumab, a TNF-α inhibitor, is widely used, yet variability in treatment response remains a challenge. Knowledge Gap: The combined relationship between smoking and key biomarkers including TNF-α, IL-6, and MMP-3 in patients receiving adalimumab has not been fully clarified. Aims: This study evaluates the association between smoking status, clinical response, and serum biomarker levels in rheumatoid arthritis patients treated with adalimumab. Results: A cross-sectional study of 75 patients and 55 controls showed that smoking prevalence was higher among non-responders, with significantly elevated TNF-α, IL-6, and MMP-3 levels and positive correlations with smoking. Novelty: The study simultaneously examines inflammatory and structural biomarkers in relation to smoking and treatment response. Implications: These findings highlight the role of smoking in persistent inflammation and suggest the relevance of MMP-3 as a biomarker for monitoring therapeutic response in clinical practice. Keywords: Rheumatoid Arthritis, Adalimumab, Smoking, Biomarkers, Inflammation Key Findings Highlights Higher cytokine and enzyme levels identified in non-responder group Significant correlation observed between tobacco exposure and inflammatory markers Distinct biomarker patterns differentiate clinical outcome groups